| 3.61 0.02 (0.56%) | 07-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.73 | 1-year : | 5.19 |
| Resists | First : | 4.05 | Second : | 4.44 |
| Pivot price | 3.82  |
|||
| Supports | First : | 3.42 | Second : | 2.84 |
| MAs | MA(5) : | 3.58 |
MA(20) : | 3.94 |
| MA(100) : | 4.58 |
MA(250) : | 5.77 |
|
| MACD | MACD : | -0.3  |
Signal : | -0.2 |
| %K %D | K(14,3) : | 14.8 |
D(3) : | 10.8 |
| RSI | RSI(14): 33.4 |
|||
| 52-week | High : | 8.5 | Low : | 3.42 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SIGA ] has closed above bottom band by 31.1%. Bollinger Bands are 48.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 3.71 - 3.73 | 3.73 - 3.75 |
| Low: | 3.55 - 3.57 | 3.57 - 3.59 |
| Close: | 3.58 - 3.61 | 3.61 - 3.64 |
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
Thu, 09 Jul 2026
3 Promising Stocks Estimated To Be Up To 26.7% Below Intrinsic Value - simplywall.st
Thu, 09 Jul 2026
Siga Technologies (NASDAQ:SIGA) Stock Price Down 3.5% - What's Next? - MarketBeat
Mon, 06 Jul 2026
Price to book forward of SIGA Technologies Inc. – NASDAQ:SIGA - TradingView
Mon, 29 Jun 2026
SIGA Technologies, Inc.(NasdaqGM: SIGA) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Tue, 23 Jun 2026
SIGA Technologies: SIGA Technologies Inc. - Cash Distribution Option Symbol: SIGA - Moomoo
Fri, 22 May 2026
Discovering SIGA Technologies And 2 Other Compelling Penny Stocks - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 72 (M) |
| Shares Float | 41 (M) |
| Held by Insiders | 42.8 (%) |
| Held by Institutions | 49.8 (%) |
| Shares Short | 3,460 (K) |
| Shares Short P.Month | 3,570 (K) |
| EPS | 0.28 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.1 |
| Profit Margin | 21.5 % |
| Operating Margin | -85.3 % |
| Return on Assets (ttm) | 5.5 % |
| Return on Equity (ttm) | 11 % |
| Qtrly Rev. Growth | -11.4 % |
| Gross Profit (p.s.) | 0.56 |
| Sales Per Share | 1.3 |
| EBITDA (p.s.) | 0.29 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 28 (M) |
| Levered Free Cash Flow | 59 (M) |
| PE Ratio | 12.44 |
| PEG Ratio | 3.3 |
| Price to Book value | 1.71 |
| Price to Sales | 2.76 |
| Price to Cash Flow | 9.33 |
| Dividend | 0.6 |
| Forward Dividend | 0 |
| Dividend Yield | 16.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|